866-997-4948(US-Canada Toll Free)

Global Therapeutic Nuclear Medicines Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Oct 2018

Category :

Pharmaceutical

No. of Pages : 114 Pages

In 2017, the global Therapeutic Nuclear Medicines market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Therapeutic Nuclear Medicines market based on company, product type, application and key regions.

This report studies the global market size of Therapeutic Nuclear Medicines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Therapeutic Nuclear Medicines in these regions.
This research report categorizes the global Therapeutic Nuclear Medicines market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Therapeutic Nuclear Medicines include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Therapeutic Nuclear Medicines include
Cardinal Health
Mallinckrodt
GE Healthcare
Lantheus Medical Imaging
Bayer
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications
IBA Molecular Imaging

Market Size Split by Type
Beta Emitters
Alpha Emitters
Brachytherapy Products
Market Size Split by Application
Thyroid
Bone Metastasis
Lymphoma
Endocrine Tumors
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Therapeutic Nuclear Medicines market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Therapeutic Nuclear Medicines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Therapeutic Nuclear Medicines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Therapeutic Nuclear Medicines with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Therapeutic Nuclear Medicines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Therapeutic Nuclear Medicines are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Therapeutic Nuclear Medicines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Therapeutic Nuclear Medicines Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type
1.4.2 Beta Emitters
1.4.3 Alpha Emitters
1.4.4 Brachytherapy Products
1.5 Market by Application
1.5.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application
1.5.2 Thyroid
1.5.3 Bone Metastasis
1.5.4 Lymphoma
1.5.5 Endocrine Tumors
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Therapeutic Nuclear Medicines Market Size
2.1.1 Global Therapeutic Nuclear Medicines Revenue 2016-2025
2.1.2 Global Therapeutic Nuclear Medicines Sales 2016-2025
2.2 Therapeutic Nuclear Medicines Growth Rate by Regions
2.2.1 Global Therapeutic Nuclear Medicines Sales by Regions
2.2.2 Global Therapeutic Nuclear Medicines Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Therapeutic Nuclear Medicines Sales by Manufacturers
3.1.1 Therapeutic Nuclear Medicines Sales by Manufacturers
3.1.2 Therapeutic Nuclear Medicines Sales Market Share by Manufacturers
3.1.3 Global Therapeutic Nuclear Medicines Market Concentration Ratio (CR5 and HHI)
3.2 Therapeutic Nuclear Medicines Revenue by Manufacturers
3.2.1 Therapeutic Nuclear Medicines Revenue by Manufacturers (2016-2018)
3.2.2 Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2016-2018)
3.3 Therapeutic Nuclear Medicines Price by Manufacturers
3.4 Therapeutic Nuclear Medicines Manufacturing Base Distribution, Product Types
3.4.1 Therapeutic Nuclear Medicines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Therapeutic Nuclear Medicines Product Category
3.4.3 Date of International Manufacturers Enter into Therapeutic Nuclear Medicines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Therapeutic Nuclear Medicines Sales by Type
4.2 Global Therapeutic Nuclear Medicines Revenue by Type
4.3 Therapeutic Nuclear Medicines Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Therapeutic Nuclear Medicines Breakdown Data by Application

6 North America
6.1 North America Therapeutic Nuclear Medicines by Countries
6.1.1 North America Therapeutic Nuclear Medicines Sales by Countries
6.1.2 North America Therapeutic Nuclear Medicines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Therapeutic Nuclear Medicines by Type
6.3 North America Therapeutic Nuclear Medicines by Application
6.4 North America Therapeutic Nuclear Medicines by Company

7 Europe
7.1 Europe Therapeutic Nuclear Medicines by Countries
7.1.1 Europe Therapeutic Nuclear Medicines Sales by Countries
7.1.2 Europe Therapeutic Nuclear Medicines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Therapeutic Nuclear Medicines by Type
7.3 Europe Therapeutic Nuclear Medicines by Application
7.4 Europe Therapeutic Nuclear Medicines by Company

8 Asia Pacific
8.1 Asia Pacific Therapeutic Nuclear Medicines by Countries
8.1.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Countries
8.1.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Therapeutic Nuclear Medicines by Type
8.3 Asia Pacific Therapeutic Nuclear Medicines by Application
8.4 Asia Pacific Therapeutic Nuclear Medicines by Company

9 Central & South America
9.1 Central & South America Therapeutic Nuclear Medicines by Countries
9.1.1 Central & South America Therapeutic Nuclear Medicines Sales by Countries
9.1.2 Central & South America Therapeutic Nuclear Medicines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Therapeutic Nuclear Medicines by Type
9.3 Central & South America Therapeutic Nuclear Medicines by Application
9.4 Central & South America Therapeutic Nuclear Medicines by Company

10 Middle East and Africa
10.1 Middle East and Africa Therapeutic Nuclear Medicines by Countries
10.1.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Countries
10.1.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Therapeutic Nuclear Medicines by Type
10.3 Middle East and Africa Therapeutic Nuclear Medicines by Application
10.4 Middle East and Africa Therapeutic Nuclear Medicines by Company

11 Company Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Therapeutic Nuclear Medicines
11.1.4 Therapeutic Nuclear Medicines Product Description
11.1.5 Recent Development
11.2 Mallinckrodt
11.2.1 Mallinckrodt Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Therapeutic Nuclear Medicines
11.2.4 Therapeutic Nuclear Medicines Product Description
11.2.5 Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Therapeutic Nuclear Medicines
11.3.4 Therapeutic Nuclear Medicines Product Description
11.3.5 Recent Development
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Therapeutic Nuclear Medicines
11.4.4 Therapeutic Nuclear Medicines Product Description
11.4.5 Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Therapeutic Nuclear Medicines
11.5.4 Therapeutic Nuclear Medicines Product Description
11.5.5 Recent Development
11.6 Bracco Imaging
11.6.1 Bracco Imaging Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Therapeutic Nuclear Medicines
11.6.4 Therapeutic Nuclear Medicines Product Description
11.6.5 Recent Development
11.7 Eczacibasi-Monrol Nuclear Products
11.7.1 Eczacibasi-Monrol Nuclear Products Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Therapeutic Nuclear Medicines
11.7.4 Therapeutic Nuclear Medicines Product Description
11.7.5 Recent Development
11.8 Nordion
11.8.1 Nordion Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Therapeutic Nuclear Medicines
11.8.4 Therapeutic Nuclear Medicines Product Description
11.8.5 Recent Development
11.9 Advanced Accelerator Applications
11.9.1 Advanced Accelerator Applications Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Therapeutic Nuclear Medicines
11.9.4 Therapeutic Nuclear Medicines Product Description
11.9.5 Recent Development
11.10 IBA Molecular Imaging
11.10.1 IBA Molecular Imaging Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Therapeutic Nuclear Medicines
11.10.4 Therapeutic Nuclear Medicines Product Description
11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Therapeutic Nuclear Medicines Raw Material
13.1.2 Therapeutic Nuclear Medicines Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Therapeutic Nuclear Medicines
Figure Global Therapeutic Nuclear Medicines Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Therapeutic Nuclear Medicines Production Market Share by Types (Product Category) in 2017
Figure Beta Emitters Product Picture
Table Major Manufacturers of Beta Emitters
Figure Alpha Emitters Product Picture
Table Major Manufacturers of Alpha Emitters
Figure Brachytherapy Products Product Picture
Table Major Manufacturers of Brachytherapy Products
Table Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Thyroid
Figure Bone Metastasis
Figure Lymphoma
Figure Endocrine Tumors
Figure Others
Figure Therapeutic Nuclear Medicines Report Years Considered
Figure Global Therapeutic Nuclear Medicines Market Size 2016-2025 (Million US$)
Figure Global Therapeutic Nuclear Medicines Sales 2016-2025 (K Units)
Table Global Therapeutic Nuclear Medicines Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Therapeutic Nuclear Medicines Sales by Regions 2016-2025 (K Units)
Table Global Therapeutic Nuclear Medicines Sales Market Share by Regions 2016-2025
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Regions 2016-2025
Figure 2017 Global Therapeutic Nuclear Medicines Sales Market Share by Regions
Table Global Therapeutic Nuclear Medicines Revenue by Regions 2016-2025 (Million US$)
Table Global Therapeutic Nuclear Medicines Revenue Market Share by Regions 2016-2025
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Regions 2016-2025
Figure 2017 Global Therapeutic Nuclear Medicines Revenue Market Share by Regions
Table Global Therapeutic Nuclear Medicines Sales by Manufacturers (2016-2018) (K Units)
Table Global Therapeutic Nuclear Medicines Sales Share by Manufacturers (2016-2018)
Figure Global Therapeutic Nuclear Medicines Sales Share by Manufacturers in 2017
Table Therapeutic Nuclear Medicines Revenue by Manufacturers (2016-2018) (Million US$)
Table Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2016-2018)
Figure Therapeutic Nuclear Medicines Value Share by Manufacturers in 2017
Table Global Therapeutic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Therapeutic Nuclear Medicines Price (2016-2018) (USD/Unit)
Table Therapeutic Nuclear Medicines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Therapeutic Nuclear Medicines Product Category
Table Date of International Manufacturers Enter into Therapeutic Nuclear Medicines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Therapeutic Nuclear Medicines Sales by Type (2016-2025) (K Units)
Table Global Therapeutic Nuclear Medicines Sales Share by Type (2016-2025)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2025)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Type in 2017
Table Global Therapeutic Nuclear Medicines Revenue by Type (2016-2025) (Million US$)
Table Global Therapeutic Nuclear Medicines Revenue Share by Type (2016-2025)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2016-2025)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Type in 2017
Table Therapeutic Nuclear Medicines Price by Type 2013-2018 (USD/Unit)
Table Global Therapeutic Nuclear Medicines Sales by Application (2016-2025) (K Units)
Table Global Therapeutic Nuclear Medicines Sales Share by Application (2016-2025)
Figure Global Sales Therapeutic Nuclear Medicines Market Share by Application (2016-2025)
Figure Global Sales Therapeutic Nuclear Medicines Market Share by Application (2016-2025)
Figure North America Therapeutic Nuclear Medicines Sales Growth Rate 2016-2025 (K Units)
Figure North America Therapeutic Nuclear Medicines Revenue Growth Rate 2016-2025 (Million US$)
Table North America Therapeutic Nuclear Medicines Sales by Countries (2016-2025) (K Units)
Table North America Therapeutic Nuclear Medicines Sales Market Share by Countries (2016-2025)
Figure 2017 North America Therapeutic Nuclear Medicines Sales Market Share by Countries
Table North America Therapeutic Nuclear Medicines Revenue by Countries (2016-2025) (Million US$)
Table North America Therapeutic Nuclear Medicines Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Therapeutic Nuclear Medicines Revenue Market Share by Countries
Figure United States Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure United States Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Canada Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Table North America Therapeutic Nuclear Medicines Sales by Type (2016-2025) (K Units)
Table North America Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2025)
Figure 2017 North America Therapeutic Nuclear Medicines Market Share by Type
Table North America Therapeutic Nuclear Medicines Sales by Application (2016-2025) (K Units)
Table North America Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2025)
Figure 2017 North America Therapeutic Nuclear Medicines Market Share by Application
Table North America Therapeutic Nuclear Medicines Sales by Company (2016-2018) (K Units)
Table North America Therapeutic Nuclear Medicines Sales Market Share by Company (2016-2018)
Figure North America Therapeutic Nuclear Medicines Sales Market Share by Company in 2017
Figure Europe Therapeutic Nuclear Medicines Sales Growth Rate 2016-2025 (K Units)
Figure Europe Therapeutic Nuclear Medicines Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Therapeutic Nuclear Medicines Sales by Countries (2016-2025) (K Units)
Table Europe Therapeutic Nuclear Medicines Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Therapeutic Nuclear Medicines Sales Market Share by Countries
Table Europe Therapeutic Nuclear Medicines Revenue by Countries (2016-2025) (Million US$)
Table Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries
Figure Germany Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Germany Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (K Units)
Figure France Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure France Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (K Units)
Figure UK Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure UK Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Italy Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Russia Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Therapeutic Nuclear Medicines Sales by Type (2016-2025) (K Units)
Table Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2025)
Figure 2017 Europe Therapeutic Nuclear Medicines Market Share by Type
Table Europe Therapeutic Nuclear Medicines Sales by Application (2016-2025) (K Units)
Table Europe Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2025)
Figure 2017 Europe Therapeutic Nuclear Medicines Market Share by Application
Table Europe Therapeutic Nuclear Medicines Sales by Company (2016-2018) (K Units)
Table Europe Therapeutic Nuclear Medicines Sales Market Share by Company (2016-2018)
Figure Europe Therapeutic Nuclear Medicines Sales Market Share by Company in 2017
Figure Asia Pacific Therapeutic Nuclear Medicines Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Therapeutic Nuclear Medicines Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Therapeutic Nuclear Medicines Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Countries
Table Asia Pacific Therapeutic Nuclear Medicines Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Countries
Figure China Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure China Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Japan Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Korea Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure India Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure India Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Australia Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Therapeutic Nuclear Medicines Sales by Type (2016-2025) (K Units)
Table Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Therapeutic Nuclear Medicines Market Share by Type
Table Asia Pacific Therapeutic Nuclear Medicines Sales by Application (2016-2025) (K Units)
Table Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Therapeutic Nuclear Medicines Market Share by Application
Table Asia Pacific Therapeutic Nuclear Medicines Sales by Company (2016-2018) (K Units)
Table Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Company (2016-2018)
Figure Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Company in 2017
Figure Central & South America Therapeutic Nuclear Medicines Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Therapeutic Nuclear Medicines Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Therapeutic Nuclear Medicines Sales by Countries (2016-2025) (K Units)
Table Central & South America Therapeutic Nuclear Medicines Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Therapeutic Nuclear Medicines Sales Market Share by Countries
Table Central & South America Therapeutic Nuclear Medicines Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Therapeutic Nuclear Medicines Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Therapeutic Nuclear Medicines Revenue Market Share by Countries
Figure Brazil Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Therapeutic Nuclear Medicines Sales by Type (2016-2025) (K Units)
Table Central & South America Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Therapeutic Nuclear Medicines Market Share by Type
Table Central & South America Therapeutic Nuclear Medicines Sales by Application (2016-2025) (K Units)
Table Central & South America Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Therapeutic Nuclear Medicines Market Share by Application
Table Central & South America Therapeutic Nuclear Medicines Sales by Company (2016-2018) (K Units)
Table Central & South America Therapeutic Nuclear Medicines Sales Market Share by Company (2016-2018)
Figure Central & South America Therapeutic Nuclear Medicines Sales Market Share by Company in 2017
Figure Middle East and Africa Therapeutic Nuclear Medicines Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Therapeutic Nuclear Medicines Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Therapeutic Nuclear Medicines Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Countries
Table Middle East and Africa Therapeutic Nuclear Medicines Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries
Figure GCC Countries Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Therapeutic Nuclear Medicines Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Therapeutic Nuclear Medicines Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Therapeutic Nuclear Medicines Market Share by Type
Table Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Therapeutic Nuclear Medicines Market Share by Application
Table Middle East and Africa Therapeutic Nuclear Medicines Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Company in 2017
Table Cardinal Health Company Details
Table Cardinal Health Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Cardinal Health Recent Development
Table Mallinckrodt Company Details
Table Mallinckrodt Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Mallinckrodt Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GE Healthcare Recent Development
Table Lantheus Medical Imaging Company Details
Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Lantheus Medical Imaging Recent Development
Table Bayer Company Details
Table Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bayer Recent Development
Table Bracco Imaging Company Details
Table Bracco Imaging Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bracco Imaging Recent Development
Table Eczacibasi-Monrol Nuclear Products Company Details
Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Eczacibasi-Monrol Nuclear Products Recent Development
Table Nordion Company Details
Table Nordion Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Nordion Recent Development
Table Advanced Accelerator Applications Company Details
Table Advanced Accelerator Applications Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Advanced Accelerator Applications Recent Development
Table IBA Molecular Imaging Company Details
Table IBA Molecular Imaging Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table IBA Molecular Imaging Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Therapeutic Nuclear Medicines Value Chain
Table Typical Suppliers of Key Therapeutic Nuclear Medicines Raw Material
Table Therapeutic Nuclear Medicines Customers List
Table Therapeutic Nuclear Medicines Sales Channels
Table Therapeutic Nuclear Medicines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *